FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Fass

Research Profile

Procedures

Chemicals & Drugs

Living Beings

Disorders

Physiology

Microbial Drug Resistance

Concepts & Ideas

Neuropsychological Tests

Co-author Network

Publications

TOP 3
Janet W Andersen; Robert J Fass; Charles van der Horst
Factors associated with early study discontinuation in AACTG studies, DACS 200.
David A Wininger; Robert J Fass
Impact of trimethoprim-sulfamethoxazole prophylaxis on etiology and susceptibilities of pathogens causing human immunodeficiency virus-associated bacteremia.
Robert J Fass; J Barnishan
Comparison of antimicrobial in vitro activities against Streptococcus pneumoniae independent of MIC susceptibility breakpoints using MIC frequency distribution curves, scattergrams and linear regression analyses.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Fass (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Janet W Andersen; Robert J Fass; Charles van der Horst
Factors associated with early study discontinuation in AACTG studies, DACS 200.
Contemporary clinical trials 2007;28(5):583-92.
2002: David A Wininger; Robert J Fass
Impact of trimethoprim-sulfamethoxazole prophylaxis on etiology and susceptibilities of pathogens causing human immunodeficiency virus-associated bacteremia.
Antimicrobial agents and chemotherapy 2002;46(2):594-7.
2001: Robert J Fass; J Barnishan
Comparison of antimicrobial in vitro activities against Streptococcus pneumoniae independent of MIC susceptibility breakpoints using MIC frequency distribution curves, scattergrams and linear regression analyses.
The Journal of antimicrobial chemotherapy 2001;48(5):609-15.
2001: Susan L Koletar; A E Heald; D Finkelstein; Richard Hafner; Judith S Currier; J Allen McCutchan; M Vallee; Francesca J Torriani; William G Powderly; Robert J Fass; Robert L Murphy
A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l.
AIDS (London, England) 2001;15(12):1509-15.
2001: Barbara A Smith; Judith L Neidig; J T Nickel; G L Mitchell; M F Para; Robert J Fass
Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults.
AIDS (London, England) 2001;15(6):693-701.
2000: R G Hewitt; C T Yiannoutsos; E S Higgs; J T Carey; P J Geiseler; R Soave; R Rosenberg; G J Vazquez; L J Wheat; Robert J Fass; Z Antoninievic; A L Walawander; T P Flanigan; J F Bender
Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(4):1084-92.
1999: Kathleen M Ingram; D A Jones; Robert J Fass; Judith L Neidig; Y S Song
Social support and unsupportive social interactions: their association with depression among people living with HIV.
AIDS care 1999;11(3):313-29.
1997: Robert J Fass
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone.
Antimicrobial agents and chemotherapy 1997;41(8):1818-24.
1997: J E Mangino; Robert J Fass
Inclusion of women in clinical trials of antiretroviral agents for HIV/AIDS during pregnancy.
Lancet 1997;350(9071):150.
1996: D A Wininger; Robert J Fass
Antibiotic-impregnated cement and beads for orthopedic infections.
Antimicrobial agents and chemotherapy 1996;40(12):2675-9.
1996: Robert J Fass; D A Goff; S J Sierawski
Candida infections in the surgical intensive care unit.
The Journal of antimicrobial chemotherapy 1996;38(5):915-6.
1996: Robert J Fass; J Barnishan; L W Ayers
The utility of non-beta-lactam antimicrobial MICs as markers to distinguish oxacillin-resistant from oxacillin-susceptible strains of Staphylococcus epidermidis.
Diagnostic microbiology and infectious disease 1996;26(1):43-5.
1996: Robert J Fass; J Barnishan; M C Solomon; L W Ayers
In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli.
Antimicrobial agents and chemotherapy 1996;40(6):1412-8.
1995: Robert J Fass; J Barnishan; L W Ayers
Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital.
The Journal of antimicrobial chemotherapy 1995;36(2):343-53.
1995: C L McDonald; W E Maher; Robert J Fass
Revised interpretation of oxacillin MICs for Staphylococcus epidermidis based on mecA detection.
Antimicrobial agents and chemotherapy 1995;39(4):982-4.
1995: D A Goff; S L Koletar; W J Buesching; J Barnishan; Robert J Fass
Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(1):77-83.
1994: Robert J Fass
Use of frequency distribution curves, scattergrams and regression analyses to compare in vitro activities and describe cross-susceptibility and cross-resistance among four quinolones.
Journal of chemotherapy (Florence, Italy) 1994;6(6):368-76.
1994: A M Podraza; R A Bornstein; C C Whitacre; Michael F Para; Robert J Fass; R R Rice; H A Nasrallah
Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infection.
Journal of clinical and experimental neuropsychology 1994;16(5):777-83.
1994: J R Black; J Feinberg; R L Murphy; Robert J Fass; D Finkelstein; B Akil; S Safrin; J T Carey; J Stansell; J F Plouffe
Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18(6):905-13.
1994: Margaret A Fischl; L Resnick; R Coombs; A B Kremer; J C Pottage; Robert J Fass; K H Fife; W G Powderly; Ann C Collier; R L Aspinall
The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3.
Journal of acquired immune deficiency syndromes 1994;7(2):139-47.
1994: R A Bornstein; H A Nasrallah; Michael F Para; C C Whitacre; Robert J Fass
Duration of illness and neuropsychological performance in asymptomatic HIV infection.
The Journal of neuropsychiatry and clinical neurosciences 1994;6(2):160-4.
1993: R A Bornstein; H A Nasrallah; Michael F Para; C C Whitacre; Robert J Fass
Change in neuropsychological performance in asymptomatic HIV infection: 1-year follow-up.
AIDS (London, England) 1993;7(12):1607-11.
1993: Robert J Fass
In vitro activity of Bay y 3118, a new quinolone.
Antimicrobial agents and chemotherapy 1993;37(11):2348-57.
1993: Robert J Fass
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance.
Antimicrobial agents and chemotherapy 1993;37(10):2080-6.
1993: Robert J Fass
Aetiology and treatment of community-acquired pneumonia in adults: an historical perspective.
The Journal of antimicrobial chemotherapy 1993;32 Suppl A():17-27.
1993: R A Bornstein; P Pace; P Rosenberger; H A Nasrallah; Michael F Para; C C Whitacre; Robert J Fass
Depression and neuropsychological performance in asymptomatic HIV infection.
The American journal of psychiatry 1993;150(6):922-7.
1993: W E Maher; M Kobe; Robert J Fass
Restriction endonuclease analysis of clinical Pseudomonas aeruginosa strains: useful epidemiologic data from a simple and rapid method.
Journal of clinical microbiology 1993;31(6):1426-9.
1993: P H Rosenberger; R A Bornstein; H A Nasrallah; Michael F Para; C C Whitaker; Robert J Fass; R R Rice
Psychopathology in human immunodeficiency virus infection: lifetime and current assessment.
Comprehensive psychiatry 1993;34(3):150-8.
1993: R A Bornstein; H A Nasrallah; Michael F Para; C C Whitacre; P Rosenberger; Robert J Fass
Neuropsychological performance in symptomatic and asymptomatic HIV infection.
AIDS (London, England) 1993;7(4):519-24.
1993: R A Bornstein; R Fama; P Rosenberger; C C Whitacre; Michael F Para; H A Nasrallah; Robert J Fass
Drug and alcohol use and neuropsychological performance in asymptomatic HIV infection.
The Journal of neuropsychiatry and clinical neurosciences 1993;5(3):254-9.
1992: W D Hardy; J Feinberg; D M Finkelstein; M E Power; W He; C Kaczka; P T Frame; M Holmes; H Waskin; Robert J Fass
A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.
The New England journal of medicine 1992;327(26):1842-8.
1992: Steffanie Sabbaj; Michael F Para; Robert J Fass; Patrick W Adams; Charles G Orosz; C C Whitacre
Quantitation of antigen-specific immune responses in human immunodeficiency virus (HIV)-infected individuals by limiting dilution analysis.
Journal of clinical immunology 1992;12(3):216-24.
1992: T J Babinchak; Robert J Fass
In vitro activity of DNA gyrase inhibitors, singly and in combination, against Mycobacterium avium complex.
Diagnostic microbiology and infectious disease 1992;15(4):367-70.
1992: R A Bornstein; Donald W Chakeres; M Brogan; H A Nasrallah; Robert J Fass; Michael F Para; C Whitacre
Magnetic resonance imaging of white matter lesions in HIV infection.
The Journal of neuropsychiatry and clinical neurosciences 1992;4(2):174-8.
1992: R A Bornstein; H A Nasrallah; Michael F Para; C C Whitacre; P Rosenberger; Robert J Fass; R Rice
Neuropsychological performance in asymptomatic HIV infection.
The Journal of neuropsychiatry and clinical neurosciences 1992;4(4):386-94.
1991: R A Bornstein; H A Nasrallah; Michael F Para; Robert J Fass; C C Whitacre; R R Rice
Rate of CD4 decline and neuropsychological performance in HIV infection.
Archives of neurology 1991;48(7):704-7.
1991: J R Black; J Feinberg; R L Murphy; Robert J Fass; J Carey; F R Sattler
Clindamycin and primaquine as primary treatment for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(3):204-7.
1991: Robert J Fass
In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci.
Antimicrobial agents and chemotherapy 1991;35(3):553-9.
1990: T E Herchline; J Barnishan; L W Ayers; Robert J Fass
Penicillinase production and in vitro susceptibilities of Staphylococcus lugdunensis.
Antimicrobial agents and chemotherapy 1990;34(12):2434-5.
1990: S L Koletar; J A Russell; Robert J Fass; J F Plouffe
Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus.
Antimicrobial agents and chemotherapy 1990;34(11):2267-8.
1990: Robert J Fass; W W Gregory; R F D'Amato; J M Matsen; D N Wright; L S Young
In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters.
Antimicrobial agents and chemotherapy 1990;34(11):2256-9.
1990: Robert J Fass
In vitro activity of BAY v 3522, a new oral cephalosporin.
Antimicrobial agents and chemotherapy 1990;34(9):1855-7.
1990: Robert J Fass
Ciprofloxacin. Best use of this new broad-spectrum antibiotic.
Postgraduate medicine 1990;87(8):117-22, 124, 127-31.
1989: T J Babinchak; Robert J Fass
Quinolone antibacterial agents for the treatment of genitourinary tract infections.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(12):1111-6.
1989: Robert J Fass; J F Plouffe; J A Russell
Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections.
The American journal of medicine 1989;87(5A):164S-168S.
1989: Robert J Fass; R B Prior
Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
Antimicrobial agents and chemotherapy 1989;33(8):1268-74.
1988: Robert J Fass; V L Helsel
In vitro activity of cefixime, a new oral cephalosporin.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1988;7(6):365-8.
1988: Robert J Fass; V L Helsel
In vitro activity of U-76,252 (CS-807), a new oral cephalosporin.
Antimicrobial agents and chemotherapy 1988;32(7):1082-5.
1987: Robert J Fass; V L Helsel
In vitro antistaphylococcal activity of pefloxacin alone and in combination with other antistaphylococcal drugs.
Antimicrobial agents and chemotherapy 1987;31(10):1457-60.
1987: Robert J Fass; E A Copelan; J T Brandt; M L Moeschberger; J J Ashton
Platelet-mediated bleeding caused by broad-spectrum penicillins.
The Journal of infectious diseases 1987;155(6):1242-8.
1987: Robert J Fass
Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.
The American journal of medicine 1987;82(4A):202-7.
1987: Robert J Fass; V L Helsel
In vitro activity of RO 23-6240 (AM-833): a new fluoroquinolone.
Diagnostic microbiology and infectious disease 1987;6(4):293-9.
1987: Robert J Fass
Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections.
Antimicrobial agents and chemotherapy 1987;31(2):148-50.
1986: Robert J Fass
Treatment of skin and soft tissue infections with oral ciprofloxacin.
The Journal of antimicrobial chemotherapy 1986;18 Suppl D():153-7.
1986: Robert J Fass; V L Helsel
In vitro activity of LY146032 against staphylococci, streptococci, and enterococci.
Antimicrobial agents and chemotherapy 1986;30(5):781-4.
1986: Robert J Fass; V L Helsel; J Barnishan; L W Ayers
In vitro susceptibilities of four species of coagulase-negative staphylococci.
Antimicrobial agents and chemotherapy 1986;30(4):545-52.
1986: Robert J Fass; V L Helsel
In vitro activities of Ro 19-5247 and Ro 15-8074, new oral cephalosporins.
Antimicrobial agents and chemotherapy 1986;30(3):429-34.
1986: Robert J Fass; V L Helsel
In vitro activity of cefpiramide (SM-1652) against gram-negative bacilli.
Diagnostic microbiology and infectious disease 1986;4(1):77-81.
1985: Robert J Fass; V L Helsel
In vitro activity of carumonam.
Antimicrobial agents and chemotherapy 1985;28(6):834-6.
1985: Robert J Fass; E H Freimer; R V McCloskey
Treatment of skin and soft tissue infections with imipenem/cilastatin.
The American journal of medicine 1985;78(6A):110-2.
1985: A L Barry; Robert J Fass; J P Anhalt; H C Neu; C Thornsberry; R C Tilton; B G Painter; J A Washington
Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks.
Journal of clinical microbiology 1985;21(6):880-3.
1985: Robert J Fass
The quinolones.
Annals of internal medicine 1985;102(3):400-2.
1985: J F Plouffe; R L Perkins; Robert J Fass; L C Carey; M E Macynski
Comparison of the effectiveness of moxalactam and cefazolin in the prevention of infection in patients undergoing abdominal operations.
Diagnostic microbiology and infectious disease 1985;3(1):25-31.
1984: Robert J Fass; V L Helsel
Comparative in vitro activities of apalcillin and piperacillin against gram-negative bacilli.
Antimicrobial agents and chemotherapy 1984;26(5):660-4.
1984: Robert J Fass; V L Helsel
Modified microdilution susceptibility test for staphylococci, streptococci and Haemophilus spp.
European journal of clinical microbiology 1984;3(4):318-9.
1984: R L Baker; Robert J Fass
Correlation of in vitro activities of cephalothin and ceftazidime with their efficacies in the treatment of Staphylococcus aureus endocarditis in rabbits.
Antimicrobial agents and chemotherapy 1984;26(2):231-4.
1984: Robert J Fass
Laboratory tests for defining bactericidal activity as predictors of antibiotic efficacy in the treatment of endocarditis due to Staphylococcus aureus in rabbits.
The Journal of infectious diseases 1984;149(6):904-12.
1984: R K Kusumi; S S Walker; P K Fulkerson; R W Henthorn; Robert J Fass
Unilateral pulmonary edema associated with left ventricular failure.
Heart & lung : the journal of critical care 1984;13(3):263-6.
1984: Robert J Fass; C A Wright
Comparative efficacies of mezlocillin and ampicillin alone or in combination with gentamicin in the treatment of Streptococcus faecalis endocarditis in rabbits.
Antimicrobial agents and chemotherapy 1984;25(4):408-10.
1983: Robert J Fass
In vitro activity of ciprofloxacin (Bay o 9867).
Antimicrobial agents and chemotherapy 1983;24(4):568-74.
1983: Robert J Fass
Comparative in vitro activities of third-generation cephalosporins.
Archives of internal medicine 1983;143(9):1743-5.
1983: Robert J Fass
Statistical comparison of the antibacterial activities of broad-spectrum penicillins against gram-negative bacilli.
Antimicrobial agents and chemotherapy 1983;24(2):156-62.
1983: E A Copelan; R K Kusumi; L Miller; Robert J Fass
A comparison of the effects of mezlocillin and carbenicillin on haemostasis in volunteers.
The Journal of antimicrobial chemotherapy 1983;11 Suppl C():43-9.
1983: Robert J Fass; V L Helsel; C A Wright
Minimal inhibitory concentrations of broad spectrum beta-lactam antibiotics for bacterial control strains.
Diagnostic microbiology and infectious disease 1983;1(1):85-8.
1983: J F Plouffe; R L Perkins; Robert J Fass; R B Prior; B Bernstein; I Ho
Cefotaxime: pharmacokinetics and in vitro antibacterial activity of serum and urine in normal human volunteers.
Chemotherapy 1983;29(2):73-9.
1982: B M Bernstein; Robert J Fass
Treatment of osteomyelitis and septic arthritis with cefamandole.
The American journal of the medical sciences 1982;284(3):2-8.
1982: T M File; Robert J Fass; R B Prior
Response of mice to transtracheal pulmonary inoculation of anaerobic bacteria.
Laboratory animals 1982;16(4):348-50.
1982: Robert J Fass
Quality control and interpretive criteria for the azlocillin disk diffusion susceptibility test.
Antimicrobial agents and chemotherapy 1982;22(1):28-31.
1982: Robert J Fass
Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolates.
Antimicrobial agents and chemotherapy 1982;22(1):167-9.
1982: Robert J Fass
Comparative in vitro activities of beta-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli.
Antimicrobial agents and chemotherapy 1982;21(6):1003-6.
1982: T G Slama; M A Apicella; R L Perkins; Robert J Fass; R W Lang; R B Prior
Detection of polysaccharide cell wall antigen of Neisseria gonorrhoeae in a rabbit model by counterimmunoelectrophoresis.
Sexually transmitted diseases 1982;9(2):70-3.
1982: R B Prior; Robert J Fass
Proposed mezlocillin disk control values for staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Pseudomonas aeruginosa ATCC 27853.
American journal of clinical pathology 1982;77(3):332-3.
1982: Robert J Fass
In-vitro activity of Sch 29482 against bacterial blood isolates.
The Journal of antimicrobial chemotherapy 1982;9 Suppl C():153-7.
1982: Robert J Fass
In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species.
Antimicrobial agents and chemotherapy 1982;21(1):188-91.
1982: Robert J Fass; R K Kusumi
Mezlocillin: treatment of skin and soft tissue infections.
The Journal of antimicrobial chemotherapy 1982;9 Suppl A():193-7.
1981: R A Shaw; Robert J Fass; R L Perkins
Fever, weight loss, and hilar adenopathy in a microbiologist.
Chest 1981;79(5):587-8.
1981: Robert J Fass; J Barnishan
In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents.
Antimicrobial agents and chemotherapy 1981;19(2):357-8.
1981: Robert J Fass
Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas species.
Antimicrobial agents and chemotherapy 1981;19(2):361-3.
1981: Robert J Fass; R B Prior
Mezlocillin susceptibility tests by the single-disk agar diffusion method.
Antimicrobial agents and chemotherapy 1981;19(2):359-60.
1980: Robert J Fass
Activity of mecillinam alone and in combination with other beta-lactam antibiotics.
Antimicrobial agents and chemotherapy 1980;18(6):906-12.
1980: Robert J Fass; J Barnishan
In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.
Reviews of infectious diseases 1980;2(6):841-53.
1980: Robert J Fass
In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophila.
Antimicrobial agents and chemotherapy 1980;18(3):483-6.
1980: R K Kusumi; J F Plouffe; R H Wyatt; Robert J Fass
Central nervous system toxicity associated with metronidazole therapy.
Annals of internal medicine 1980;93(1):59-60.
1980: Robert J Fass
In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
Archives of internal medicine 1980;140(6):763-8.
1980: J F Plouffe; Robert J Fass
Histoplasma meningitis: diagnostic value of cerebrospinal fluid serology.
Annals of internal medicine 1980;92(2 Pt 1):189-91.
1979: Robert J Fass; J Barnishan
Minimal inhibitory concentrations of 34 antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853.
Antimicrobial agents and chemotherapy 1979;16(5):622-4.
1979: Robert J Fass
In vitro activity of LY127935.
Antimicrobial agents and chemotherapy 1979;16(4):503-9.
1979: Robert J Fass; J Barnishan
Effect of divalent cation concentrations on the antibiotic susceptibilities of nonfermenters other than Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy 1979;16(4):434-8.
1979: K R Brinker; G Paulson; T P Monath; G Wise; Robert J Fass
St Louis encephalitis in Ohio, September 1975: clinical and EEG studies in 16 cases.
Archives of internal medicine 1979;139(5):561-6.
1979: T G Slama; L C Carey; Robert J Fass
Comparative efficacy of prophylactic cephalothin and cefamandole for elective colon surgery: results of a prospective, randomized, double-blind study.
American journal of surgery 1979;137(5):593-6.
1979: T M File; J Barnishan; Robert J Fass
Campylobacter fetus sepsis with mycotic aortic aneurysm.
Archives of pathology & laboratory medicine 1979;103(3):143-5.
1979: R L Perkins; T G Slama; Robert J Fass; R B Prior; J F Plouffe; J F Warner; T M File
Therapy of skin, soft tissue, and bone infections with cefoxitin sodium.
Reviews of infectious diseases 1979;1(1):165-9.
1978: J W Crum; Robert J Fass; J D Pollack
Reduced level of non-esterified fatty acids in sera from patients with infectious respiratory disease.
Clinica chimica acta; international journal of clinical chemistry 1978;88(3):517-22.
1978: R B Prior; Robert J Fass
Proposed ticarcillin disk control values for Escherichia coli and Pseudomonas aeruginosa: multicenter cooperative study.
Antimicrobial agents and chemotherapy 1978;14(3):507-8.
1978: V A Spagna; Robert J Fass; R B Prior; T G Slama
Report of a case of bacterial sepsis caused by a naturally occurring variant form of Staphylococcus aureus.
The Journal of infectious diseases 1978;138(2):277-8.
1978: R L Perkins; Robert J Fass; J F Warner; R B Prior; T M File; R R Tight; W G Gardner; D E Ruiz; T G Slama
Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients.
The Journal of infectious diseases 1978;137 Suppl():S110-S118.
1978: R B Prior; Robert J Fass; R L Perkins
A single large dose of trimethoprim-sulfamethoxazole fails to cure gonococcal urethritis in men.
Sexually transmitted diseases 1978;5(2):62-4.
1978: Robert J Fass
Treatment of osteomyelitis and septic arthritis with cefazolin.
Antimicrobial agents and chemotherapy 1978;13(3):405-11.
1978: R B Prior; Robert J Fass
Comparison of ticarcillin and carbenicillin activity against random and select populations Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy 1978;13(2):184-7.
1977: Robert J Fass; R B Prior
In vitro activity of spectinomycin against recent urinary tract isolates.
Antimicrobial agents and chemotherapy 1977;12(4):551-4.
1977: T M File; Robert J Fass; R L Perkins
Pneumonia and empyema caused by Clostridium sordellii.
The American journal of the medical sciences 1977;274(2):211-2.
1977: Robert J Fass; R B Prior; R L Perkins
Pharmacokinetics and tolerance of a single twelve-tablet dose of trimethoprim (960 mg)-sulfamethoxazole (4,800 mg).
Antimicrobial agents and chemotherapy 1977;12(1):102-6.
1977: Robert J Fass
Treatment of mixed bacterial infections with clindamycin and gentamicin.
The Journal of infectious diseases 1977;135 Suppl():S74-9.
1977: Robert J Fass; D E Ruiz; W G Gardner; C A Rotilie
Clindamycin and gentamicin for aerobic and anaerobic sepsis.
Archives of internal medicine 1977;137(1):28-38.
1976: R B Prior; Robert J Fass; R L Perkins
Regression-line analysis of trimethoprim-sulfamethoxazole activity against Neisseria gonorrhoeae.
American journal of clinical pathology 1976;66(3):605-9.
1976: Robert J Fass; D E Ruiz; R B Prior; R L Perkins
In vitro activity of gentamicin and minocycline alone and in combination against bacteria associated with intra-abdominal sepsis.
Antimicrobial agents and chemotherapy 1976;10(1):34-7.
1976: R L Perkins; S Saslaw; Robert J Fass; R B Prior; J F Scholand; G R Hodges; R R Tight; W G Gardner
Tobramycin: in vitro and clinical evaluation in 30 patients.
The American journal of the medical sciences 1976;271(3):297-308.
1976: Robert J Fass; J Barnishan
Letter: Acute meningitis due to a Pseudomonas-like Group Va-1 bacillus.
Annals of internal medicine 1976;84(1):51-2.
1975: Robert J Fass; R B Prior; C A Rotilie
Simplified method for antimicrobial susceptibility testing of anaerobic bacteria.
Antimicrobial agents and chemotherapy 1975;8(4):444-52.
1975: C A Rotilie; Robert J Fass; R B Prior; R L Perkins
Microdilution technique for antimicrobial susceptibility testing of anaerobic bacteria.
Antimicrobial agents and chemotherapy 1975;7(3):311-15.
1974: Robert J Fass
Sexual transmission of viral hepatitis?
JAMA : the journal of the American Medical Association 1974;230(6):861-2.
1974: Robert J Fass; C A Rotilie; R B Prior
Interaction of clindamycin and gentamicin in vitro.
Antimicrobial agents and chemotherapy 1974;6(5):582-7.
1974: Robert J Fass; R B Prior
Light, scanning, and transmission electron microscopy of stable staphylococcal L-forms.
Annals of the New York Academy of Sciences 1974;236(0):76-95.
1974: J F Scholand; G R Hodges; Robert J Fass; S Saslaw
Clinical evaluation of cephradine, a new oral cephalosporin.
The American journal of the medical sciences 1974;267(2):111-6.
1973: Robert J Fass; A S Klainer; R L Perkins
Urinary tract infection. Practical aspects of diagnosis and treatment.
JAMA : the journal of the American Medical Association 1973;225(12):1509-13.
1973: Robert J Fass; J F Scholand; G R Hodges; S Saslaw
Clindamycin in the treatment of serious anaerobic infections.
Annals of internal medicine 1973;78(6):853-9.
1973: Robert J Fass
Morphology and ultrastructure of staphylococcal L colonies: light, scanning, and transmission electron microscopy.
Journal of bacteriology 1973;113(2):1049-53.
1972: Robert J Fass; S Saslaw
Chronic meningococcemia. Possible pathogenic role of IgM deficiency.
Archives of internal medicine 1972;130(6):943-6.
1972: G R Hodges; Robert J Fass; S Saslaw
Central nervous system disease associated with Mycoplasma pneumoniae infection.
Archives of internal medicine 1972;130(2):277-82.
1972: Robert J Fass; S Saslaw
Clindamycin: clinical and laboratory evaluation of parenteral therapy.
The American journal of the medical sciences 1972;263(5):368-82.
1971: Robert J Fass; S Saslaw
Earth day histoplasmosis. A new type of urban pollution.
Archives of internal medicine 1971;128(4):588-90.
1971: C Watanakunakorn; Robert J Fass; A S Klainer; M Hamburger
Light and scanning-beam electron microscopy of wall-defective Staphylococcus aureus induced by lysostaphin.
Infection and immunity 1971;4(1):73-8.
1971: Robert J Fass; R L Perkins
5-fluorocytosine in the treatment of cryptococcal and candida mycoses.
Annals of internal medicine 1971;74(4):535-9.
1970: Robert J Fass; J Carleton; C Watanakunakorn; A S Klainer; M Hamburger
Scanning-beam electron microscopy of cell wall-defective staphylococci.
Infection and immunity 1970;2(4):504-15.
1970: Robert J Fass; R L Perkins; S Saslow
Positive direct Coombs' tests associated with cephaloridine therapy.
JAMA : the journal of the American Medical Association 1970;213(1):121-3.
1970: Robert J Fass; R L Perkins; S Saslaw
Cephalexin--a new oral cephalosporin: clinical evaluation in sixty-three patients.
The American journal of the medical sciences 1970;259(3):187-200.